SNDX
NASDAQ
$22.29
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company is headquartered in Waltham, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $39 (+74.97%)
Market Cap
$2.08B
Revenue 5Y CAGR
+169.88%
FCF 5Y CAGR
+29.00%
Free Cash Flow Yield
-13.37%
Price Chart
Valuation
Market Cap$2.08B
P/S9.85
P/B51.39
Profitability
Total Revenue (TTM)$217M
Gross Profit (TTM)-$50M
EBITDA-$214M
Profit Margin-65.8%
Operating Margin-52.7%
EPS-$2.79
Financial Health
Debt-to-Equity840.9%
Free Cash Flow Yield-13.37%
Growth & Risk
EPS 5Y CAGR+12.13%
Revenue 5Y CAGR+169.88%
FCF 5Y CAGR+29.00%
Beta (5Y)1.03
Sharpe Ratio1.68